6MK:ETR
Merck & Co Inc
€125.74
arrow_upward
+1.06%(+1.32) 1D
Oct 6, 5:35:40 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 6MK...
Open
€124.96
High
€125.80
Low
€123.54
Mkt. cap
362.14B
Avg. vol.
1.25K
Volume
1.98K
52-wk high
€134.48
52-wk low
€71.00
No. of employees
74K
Open
€124.96
High
€125.80
Low
€123.54
Mkt. cap
362.14B
Avg. vol.
1.25K
Volume
1.98K
52-wk high
€134.48
52-wk low
€71.00
No. of employees
74K
News stories
From web sources and news partners
Yahoo Finance Singapore
·
4 hours ago
Merck (MRK) Beats Stock Market Upswing: What Investors Need to Know
The Globe and Mail
·
8 hours ago
Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity?
MarketBeat
·
16 hours ago
Merck & Co., Inc. (NYSE:MRK) Stock Has Consensus Price Target of $146.36
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74K
FoundedJan 1, 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com